about
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular CarcinomaTicks and Tick Bites Presenting as "Funny Moles": A Review of Different Presentations and a Focus on Tick-borne Diseases.Rugby injury-associated pseudocyst of the auricle: report and review of sports-associated dermatoses of the ear.Lentigo maligna: review of salient characteristics and management.Tinea versicolor in dark-skinned individuals.Schwannoma of the left foot: a brief overview with focus on associated clinical syndromes.Squamous cell carcinoma of the skin: epidemiology, classification, management, and novel trends.90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.Hepatic imaging following intra-arterial embolotherapy.Types of Research Bias Encountered in IR.New Developments in Interventional Oncology: Liver Metastases From Colorectal Cancer.Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and Survival.Comparison of the Adverse Event Profile of TheraSphere® with SIR-Spheres® for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review.Paraneoplastic palmoplantar keratoderma secondary to metastatic uterine adenocarcinoma.Multiple hyperpigmented macules on the torso of a dark-skinned man.Y90 Radioembolization for Locally Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Long-Term Outcomes in a 185-Patient Cohort.Institutional Decision to Adopt Y90 as Primary Treatment for HCC Informed by a 1,000-patient 15-year Experience.Z-Plasty for Alar Groove Correction.Pictorial essay: imaging findings following Y90 radiation segmentectomy for hepatocellular carcinoma.Pretransplant Intra-arterial Liver-Directed Therapy Does Not Increase the Risk of Hepatic Arterial Complications in Liver Transplantation: A Single-Center 10-Year Experience.Commentary on: "Occupational radiation exposure of medical staff performing ⁹⁰Y-loaded microsphere radioembolization".Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma.Noncirrhotic complete obliterative portal vein thrombosis: Novel management using trans-splenic transjugular intrahepatic portosystemic shunt with portal vein recanalization.Fluoroscopic Radiation Exposure in Chemoembolization and Radioembolization: Results from a Prospective Randomized Study.A cost-effective alternative formulation of ultrasound phantom for vascular access instruction: Cost-effective hands-on procedural trainingReplyRadioembolization Super Survivors: Extended Survival in Non-operative Hepatocellular CarcinomaProstate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption StudyContemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular CarcinomaMR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 studyA Simple Approach to Gastrojejunostomy Tube Exchange Complicated by Clogged Jejunal Port
P50
Q26753089-BBDE2B14-7D14-4BCA-A7F7-A13FD5D6F7A5Q37723078-2327542E-120E-4154-A4A4-A44E7A3A7BBEQ38087677-E21DF5F2-8D35-4142-8052-B7584C94BA5DQ38135777-38203E3F-B25E-4B41-96CF-262130DB549BQ38169760-D8977683-27D5-4F98-8EEE-39E5630DAA1DQ38256092-D927FF17-8D3B-4FE3-B6D0-71DD828875DEQ38271835-FE5A3E39-2E13-41F7-ABC5-29A88D2EB69CQ38658822-8D9E0CFA-8373-44CE-9208-4BBE7FC20D62Q38716483-0D884FEE-EC18-4917-81D3-B7632137E73DQ38762954-9A4141BF-C872-4F3E-95D8-AA84DF08D774Q38792621-DAC2E20B-82E9-4FF5-996A-27BBD98AC026Q38803399-02FE1EDD-F584-4BEC-AB74-8EFEDFE5A60AQ38936579-47730F12-6975-4338-BCC0-953A315B329DQ39234211-E04141FF-B245-44A5-AA15-3B8CE6DC991CQ43649793-CE2D3C86-90A0-4C3A-904F-1021B05F6F4FQ47347973-BCAB8A66-39E7-40A7-86CE-266C994C6BB3Q47384456-F83E6A1E-2017-41C4-9163-8057B68C8195Q47755910-43265DD1-007C-417C-9315-06A24F731023Q48285755-0E0B63B3-D216-44CD-9CF7-A2907BCBFF3EQ50125448-0EBBE5C8-2892-4A5A-A970-30037BD69331Q51535074-A65AA006-E863-4DF6-B510-63E7C26B3E74Q52893237-AAD32BA7-7D62-4046-8C2C-AEF34A17A163Q52986127-97982922-5827-4155-809D-9CFD6A065993Q54530794-51BDBCF3-A54F-468F-B1E5-3D64278B9D6BQ87985899-4C5F0870-77A1-4C97-9F6F-FBD8E6C025ACQ89071030-AFC98574-C97A-47FA-9442-7B25A42005D4Q89282153-9E645A90-2507-4DAC-A371-D125499AAE18Q90417129-5D2F67BF-CD7A-4EE6-AA1B-574BB2BA7EA1Q91103490-15C3E09A-8486-4473-AA11-C202E43CAECFQ91342917-6C268F69-6AB5-4B02-8D20-147E82D65617Q91944726-A9F64175-0A09-4BE1-8F6C-4AFFE9297DD9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joseph R. Kallini
@ast
Joseph R. Kallini
@en
Joseph R. Kallini
@es
Joseph R. Kallini
@nl
Joseph R. Kallini
@sl
type
label
Joseph R. Kallini
@ast
Joseph R. Kallini
@en
Joseph R. Kallini
@es
Joseph R. Kallini
@nl
Joseph R. Kallini
@sl
prefLabel
Joseph R. Kallini
@ast
Joseph R. Kallini
@en
Joseph R. Kallini
@es
Joseph R. Kallini
@nl
Joseph R. Kallini
@sl
P106
P1153
55612407000
P21
P31
P496
0000-0003-3010-9202